Genetic apo (a) isoforms were originally defined according to their relative mobility in SDS-
PAGE compared to apoB-100 and were designated as F, B or S1–S4 isotypes. This widely …

INTRODUCTION: Cardio-and/or cerebro-vascular risk are associated with high lipoprotein
(a)[Lp (a)] levels and low-molecular-weight (LMW) apo (a) isoforms. Aims of this study were …

Apolipoprotein [a] phenotyping is a critically important method to explore the role of kringle-4
repeat number as a modulator of lipoprotein [a]-associated cardiovascular risk. The …

Lipoprotein (a) resembles low density lipoprotein in structure, except that a unique
apolipoprotein (apo), apo (a), is linked to apo B‐100. Variations in the number of sequence …

Apo (a), the specific lipoprotein (a)(Lp (a)) apolipoprotein, is characterized by different
isoforms (from 6 to 11 on SDS-PAGE) encoded by a system of autosomal codominant …

The size of apolipoprotein (a)[apo (a)] varies from 187 to 648 kDa because of interallelic
differences in the number of kringle 4-encoding sequences in the apo (a) gene. Plasma apo …

Hypercholesterolemia is frequently associated with elevated Lp (a) levels, an independent
risk factor for coronary, cerebrovascular, and peripheral vascular disease. A portion of …

Elevated concentrations of lipoprotein (a)(Lp [a]) in plasma are associated with premature
coronary heart disease (CHD). Lp (a) levels are largely determined by alleles at the …

It is well recognized that blood lipoprotein A [Lp (a)] levels constitute an important risk factor
for atherosclerotic vascular disease. In some populations, mainly Caucasian, Lp (a) levels …

Several studies indicate that the inter-individual variation in plasma concentrations of
lipoprotein (a)(Lp (a)) is mainly under genetic control. To define the effect of three DNA …